ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 288.83%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+288.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.34B
AUM Growth
+$327M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
284
New
Increased
Reduced
Closed

Top Buys

1 +$31.8M
2 +$14.2M
3 +$12.6M
4
TERN icon
Terns Pharmaceuticals
TERN
+$12.3M
5
ABUS icon
Arbutus Biopharma
ABUS
+$11.3M

Top Sells

1 +$94.2M
2 +$31.1M
3 +$15.5M
4
MTSR
Metsera Inc
MTSR
+$7.98M
5
IVVD icon
Invivyd
IVVD
+$7.22M

Sector Composition

1 Healthcare 90.32%
2 Financials 1.75%
3 Real Estate 0.13%
4 Communication Services 0.08%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDXX icon
201
Idexx Laboratories
IDXX
$50.8B
$271K 0.02%
+400
SPRO icon
202
Spero Therapeutics
SPRO
$123M
$265K 0.02%
113,839
-1,700
CATX icon
203
Perspective Therapeutics
CATX
$609M
$262K 0.02%
+95,193
IMMX icon
204
Immix Biopharma
IMMX
$443M
$262K 0.02%
+50,000
JSPR icon
205
Jasper Therapeutics
JSPR
$37.8M
$256K 0.02%
+140,000
SNDX icon
206
Syndax Pharmaceuticals
SNDX
$1.92B
$252K 0.02%
+12,000
OGN icon
207
Organon & Co
OGN
$1.87B
$251K 0.02%
35,000
+25,000
ANNX icon
208
Annexon
ANNX
$823M
$241K 0.02%
+48,000
PEPG icon
209
PepGen
PEPG
$449M
$240K 0.02%
36,842
EOLS icon
210
Evolus
EOLS
$278M
$238K 0.02%
+35,859
ACHV icon
211
Achieve Life Sciences
ACHV
$246M
$238K 0.02%
47,800
BCAX
212
Bicara Therapeutics
BCAX
$964M
$231K 0.02%
13,705
RXST icon
213
RxSight
RXST
$313M
$227K 0.02%
+21,803
MIST icon
214
Milestone Pharmaceuticals
MIST
$147M
$202K 0.02%
+100,100
WHWK
215
Whitehawk Therapeutics
WHWK
$153M
$188K 0.01%
+77,593
TRAW icon
216
Traws Pharma
TRAW
$12.9M
$175K 0.01%
+154,431
KALV icon
217
KalVista Pharmaceuticals
KALV
$812M
$162K 0.01%
10,000
RLMD icon
218
Relmada Therapeutics
RLMD
$355M
$149K 0.01%
+30,866
VYNE icon
219
VYNE Therapeutics
VYNE
$20.1M
$147K 0.01%
+253,791
QNCX icon
220
Quince Therapeutics
QNCX
$5.5M
$144K 0.01%
42,912
-732,122
SLN
221
Silence Therapeutics
SLN
$282M
$144K 0.01%
23,643
+5,000
RXRX icon
222
Recursion Pharmaceuticals
RXRX
$1.89B
$143K 0.01%
35,000
VYGR icon
223
Voyager Therapeutics
VYGR
$231M
$138K 0.01%
35,000
ZONE
224
CleanCore Solutions
ZONE
$2.66M
$136K 0.01%
+521,980
CMMB
225
Chemomab Therapeutics
CMMB
$12.1M
$132K 0.01%
+80,000